NXC-828

N/A

Report date: 2025/01/26 16:38:55
NME

Base Information

Drug NameNXC-828
Drug Alias NameNXC-828
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsHypoxia-inducible factor 1 alpha inhibitors
TargetsVascular endothelial growth factor receptorHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNextgen Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesNextgen Bioscience Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A